Shield Therapeutics PLC (LON:STX) said it will be adopting the Quoted Companies Alliance Corporate Governance Code.
The QCA champions the interests of the 1,250 small- and medium-sized listed firms in the UK.
Its code is described as a “practical, outcome-oriented" approach to corporate oversight.
Shield said it won’t make any changes to its board composition, constitution or other governance aspects.
Chairman James Karis said: "High standards of corporate governance are fundamental to the continued growth and development of Shield.
“The board and its committees play a key role in ensuring these high standards are supported through internal frameworks, policies and procedures for the long-term benefit of our shareholders."